Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oren Gilad Insider Profile
4 Followers
Oren Gilad, President & CEO, Director at Aprea Therapeutics, holds 335.19K shares in Aprea Therapeutics (Ticker: APRE). Most recently, Oren Gilad Bought $500 shares of Aprea Therapeutics on Oct 24, 2024 for an estimated value of 1.96K.
Oren Gilad Aprea Therapeutics (APRE)President & CEO, Director
Aprea Therapeutics (APRE)
President & CEO, Director
Ranked #58,461 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-6.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Oren Gilad holds in companies
Most Profitable Insider Trade
The most profitable trade made by Oren Gilad
Oren Gilad's Trading History
List of latest transactions for each holding click on a transaction to see Oren Gilad's performance on stock
You May Also Like
Oren Gilad insider profile FAQ
What is the percentage of profitable transactions made by Oren Gilad?
The percentage of profitable transactions made by Oren Gilad is 50%.
What is the average return per transaction made by Oren Gilad?
The average return per transaction made by Oren Gilad is -6.00%.
What stocks does Oren Gilad hold?
Oren Gilad holds: APRE stocks.
What was Oren Gilad’s latest transaction?
Oren Gilad latest transaction was an Informative Buy of $1.96K.
What was Oren Gilad's most profitable transaction?
Oren Gilad’s most profitable transaction was an Informative Buy of APRE stock on October 15, 2024. The return on the trade was 16.30%.
What is Oren Gilad's role in Aprea Therapeutics?
Oren Gilad's role in Aprea Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.